Earnings call transcript: Bumrungrad posts mixed Q2 2026 results as revenue beats forecast

Bumrungrad Hospital reported mixed Q2 2026 results, with earnings per share below expectations but revenue surpassing forecasts. The company's international business, particularly from Middle East, Myanmar, and U.S. patients, helped offset weaker domestic demand. Despite a modest earnings miss, Bumrungrad maintained strong margins and solid profitability, with EBITDA and net profit both increasing year-over-year.

The stock rose after the report, trading near the top of its 52-week range, indicating a relatively strong valuation.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.